Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

NCT03389893 ·Status: TERMINATED ·Phase: PHASE4

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

NCT07105488 ·Status: RECRUITING ·Phase: PHASE2

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

NCT05694884 ·Status: RECRUITING ·Phase: PHASE2

The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients

NCT03667014 ·Status: COMPLETED ·Phase: PHASE4

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

NCT02277743 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis

NCT03736967 ·Status: TERMINATED ·Phase: PHASE2

Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

NCT05590585 ·Status: COMPLETED ·Phase: PHASE4

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

NCT02277769 ·Status: COMPLETED ·Phase: PHASE3

A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)

NCT02395133 ·Status: COMPLETED ·Phase: PHASE3

Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

NCT01859988 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

NCT05656911 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis

NCT04307862 ·Status: UNKNOWN ·Phase: PHASE2

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

NCT05432596 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

NCT07235384 ·Status: RECRUITING ·Phase: PHASE1

Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT04195698 ·Status: COMPLETED ·Phase: PHASE3

Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab

NCT05602207 ·Status: COMPLETED ·Phase: PHASE4

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

NCT04256174 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT03720470 ·Status: COMPLETED ·Phase: PHASE3

Study in Subjects With Moderate Atopic Dermatitis

NCT03859986 ·Status: UNKNOWN ·Phase: PHASE2

Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy

NCT01149759 ·Status: COMPLETED ·Phase: NA

Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

NCT05990725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)

NCT02210780 ·Status: COMPLETED ·Phase: PHASE2

Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis

NCT04718870 ·Status: COMPLETED ·Phase: PHASE4

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

NCT03345914 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis

NCT03054428 ·Status: COMPLETED ·Phase: PHASE3